NSB 9.30% 3.9¢ neuroscientific biopharmaceuticals ltd

Potential 100 bagger Biotech missed by the market, page-15

  1. 135 Posts.
    lightbulb Created with Sketch. 21
    Let's not get too carried away too early, this article outlines the road ahead including drug failure rate and approval timelines to give you some idea of the risk profile.
    https://www.medicinenet.com/script/main/art.asp?articlekey=9877
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.